Alignment Healthcare, Inc. reports developments tied to its Medicare Advantage business for seniors, including health plan membership, revenue growth, adjusted gross profit, adjusted EBITDA and annual guidance. The company operates under the Alignment Health consumer brand and works with local provider partners to deliver coordinated care through a customized care model, a 24/7 concierge care team and the AVA® technology platform.
Recurring updates include quarterly and full-year results, membership outlooks for HMO and PPO contracts, Medicare Advantage operating trends, investor conference presentations and registered offerings involving common stock. News also follows the company's expansion of health plan offerings and national footprint within senior care.
Alignment Healthcare (NASDAQ: ALHC) has released its 2024 Impact Report, highlighting significant improvements in senior healthcare delivery. The company achieved 100% enrollment in 4-star or higher-rated plans, up from 90% in 2023, while maintaining an impressive Net Promoter Score of 61, well above the industry average of 40.
Key achievements include a 35% increase in Care Anywhere program membership to 11,500 members, a 95% year-over-year increase in ACCESS card transactions to 3.1 million, and an 86% expansion in caregiver benefit access. The company reported its lowest hospitalization rate to date at 149 per 1,000 members, a 4.5% improvement from 2023, and achieved 47% fewer skilled nursing facility admissions compared to the 2019 Medicare benchmark.
Alignment Healthcare (NASDAQ: ALHC) has scheduled its second quarter 2025 financial results announcement for Wednesday, July 30, 2025, after market close. The company will host a conference call at 5 p.m. EDT to discuss the results.
Investors can access the live audio webcast through the company's investor relations website at ir.alignmenthealth.com. A replay of the call will be available for approximately 12 months following the event.
Alignment Healthcare (NASDAQ: ALHC) secured a significant legal victory against CMS, resulting in the elevation of its Arizona HMO 2025 star rating from 3.5 to 4 stars. Following this court ruling on June 9, 100% of Alignment's Medicare Advantage members are now enrolled in plans rated 4 stars or higher.
The company serves approximately 217,500 Medicare beneficiaries across five states: Arizona, California, Nevada, North Carolina, and Texas. The upgraded rating qualifies Alignment for CMS bonus payments, which will be reinvested to enhance member benefits and services. The company maintains a 4.9 out of 5-star Google rating and was recognized as a Newsweek World's Most Trustworthy Company 2024.
Alignment Healthcare (NASDAQ: ALHC) has announced its participation in the upcoming William Blair 45th Annual Growth Stock Conference. The company's presentation is scheduled for Wednesday, June 4, at 2 p.m. CDT. Interested parties can access both the live webcast and replay of the presentation through Alignment's investor relations website at https://ir.alignmenthealth.com/.
Alignment Healthcare (NASDAQ: ALHC) has received the 2025 PQA Laura Cranston Excellence in Quality Award for its Medicare Advantage prescription drug (MAPD) plan. The company was one of only two MAPD plans out of 633 eligible contracts to achieve this recognition, representing the top 1.3%. The award requires a minimum 4.5-star Part D summary rating and a perfect 5-star rating on all five PQA medication measures used in CMS's star ratings program.
The recognition marks Alignment's sixth time receiving this honor, having previously won the PQA Excellence in Quality Award from 2018 to 2022. The company achieved perfect ratings in medication adherence for diabetes, hypertension, and cholesterol medications, as well as in medication therapy management program completion and statin use in persons with diabetes.
Alignment Healthcare (NASDAQ: ALHC) has announced its upcoming participation at the BofA Securities Healthcare Conference. The presentation is scheduled for Wednesday, May 14, at 2:20 p.m. PDT.
Interested parties can access both the live webcast and replay of the presentation through Alignment's investor relations website at https://ir.alignmenthealth.com/.
Alignment Healthcare (NASDAQ: ALHC) has announced two key leadership appointments to enhance its AI-enabled Medicare Advantage platform. Dr. Arta Bakshandeh has been named President of AVA®, the company's proprietary platform that utilizes 200+ data sources and 13,000+ attributes for personalized healthcare insights. Aly Duzich has been promoted to Chief Experience Officer to optimize member experience.
AVA platform leverages trusted AI to improve senior health outcomes and quality of care while reducing costs. The company has grown to over 200,000 health plan members since its IPO in March 2021. Both appointments aim to strengthen Alignment's care management and service delivery approach, integrating technology with compassionate care for seniors.